Tilray stock soars 10% after company tapped to provide medical cannabis in French study

Tilray's products will treat patients with neuropathic pain, epilepsy and multiple sclerosis who aren't getting relief from existing treatments.

from Health and Science https://ift.tt/3sYxaTl
https://ift.tt/eA8V8J
https://ift.tt/2zIUzyH